News

Zhimeng Biopharma's Next-Generation KCNQ2/3 Potassium Channel Opener Receives Clinical Trial Approval for ALS Phase 2/3 Study
Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative drug development for liver and central nervous system (CNS) diseases, today ...
Recall alert for parents as ACCC warns of ‘serious injury’ risk from products sold on baby retailer Ezone
Parents are being warned to immediately stop using the two items amid fears they could cause ‘serious injury’ or death.